SCIMITAR EQUITY
About Us Equity Research Disclosure Contact







Earnings and Price Disclosures

Reg, AC, Analysts Certification


Company Specific Disclosure


Regulatory Disclosure


Legal Disclaimer


Estimates, Models and Valuation Methodology


Managing Conflicts of Interest
in Equity Research


Transparency of Analyst's Performance


Compensation for Product and Services Disclosures


Investment Suitability


Research Coverage Universe


Stock Ranking System


Distribution of Rankings


Company Ranking Time
Definition


Research Dissemination


Valuation Methodology


Earnings and Price Disclosures


Privacy Policy


Disclosures Supporting Reporting



Earnings and Price Disclosures

print this page

Risks associated with the achievement of investment price targets include, but are not limited to, the company's failure to achieve an analyst's earnings and revenue estimates. Unforeseen macroeconomic and/or industry events could adversely impact the company's scientific development cycle, issues related to revolving investor or industry sentiment , the ever present regulatory concerns of the FDA, the company's ability to attract talent, and finally just adverse market conditions. Discussion of the risk factors that affect the market price of the company's shares, should be reviewed in the most recent form 10-Q or 10-K that a company must file with the SEC. Make sure you read and review these disclosures.